OncoZenge AB (publ) ("OncoZenge" or "the Company") today announced a comprehensive market and strategy update after successfully securing full funding for its BupiZenge™ Phase 3 clinical trial aimed ...

Texas Lawyer and Law.com are proud to announce the finalists and winners of the 2025 Texas Legal Awards. Congratulations, and ...